Brief: EMD Serono Announces Agreement With U.S. Government To Expand Access To IVF Therapies

Merck KGaA

16/10/2025 20:46

Oct 16 (Reuters) - EMD SERONO:

EMD SERONO ANNOUNCES UNPRECEDENTED AGREEMENT WITH  U.S. GOVERNMENT TO EXPAND ACCESS TO IVF THERAPIES

EMD SERONO: WILL FILE PERGOVERIS FOR REVIEW UNDER THE FDA COMMISSIONER'S NATIONAL PRIORITY VOUCHER PROGRAM

EMD SERONO: WILL PARTICIPATE IN THE TRUMPRX.GOV DIRECT PURCHASING PLATFORM

EMD SERONO: ENTERED AGREEMENT WITH THE U.S. SECRETARY OF COMMERCE TO EXCLUDE ITS PHARMACEUTICAL PRODUCTS, INGREDIENTS FROM SECTION 232 TARIFFS

EMD SERONO: WHEN ALL THREE OF ITS IVF THERAPIES ARE USED IN A TYPICAL IVF PROTOCOL, PATIENTS WILL ACCESS AN 84% DISCOUNT OFF LIST PRICES

Further company coverage: MRCG.DE

 ((Reuters.Briefs@thomsonreuters.com;))